Columbus, OH5 Active Studies

Geographic Atrophy Clinical Trials in Columbus, OH

Find 5 actively recruiting geographic atrophy clinical trials in Columbus, OH. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
676
Enrolling

Recruiting Geographic Atrophy Studies in Columbus

RecruitingColumbus, OHNCT06963827

A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition

Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that build-up in the kidneys causing swelling (...

347 participants
Takeda
View Study Details
RecruitingColumbus, OHNCT06930625

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

The primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind per...

119 participants
Debiopharm International SA
View Study Details
RecruitingColumbus, OHNCT04468061

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts ...

110 participants
Dana-Farber Cancer Institute
View Study Details
RecruitingColumbus, OHNCT03546686

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

The purpose of this study is to determine the impact of pre-operative cryoablation, and immune checkpoint inhibition (ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone recept...

80 participants
University of Texas Southwestern Medical Center
View Study Details
RecruitingColumbus, OHNCT03266640

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovi...

20 participants
New York Medical College
View Study Details

About Geographic Atrophy Clinical Trials in Columbus

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 5 geographic atrophy clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 676 participants. Research is being sponsored by Takeda, Debiopharm International SA, Dana-Farber Cancer Institute and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Columbus — FAQ

Are there geographic atrophy clinical trials in Columbus?

Yes, there are 5 geographic atrophy clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbus?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.

Are clinical trials in Columbus free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 5 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov